Kojin Therapeutics
Boston, United States · $60.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Business Model
- B2B
- Total Funding
- $60.0M
- Last Round
- $60.0M Series AJun 2021
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.
About
Biopharmaceutical company developing novel therapeutics based on ferroptosis and cell state biology.
Summary
Kojin Therapeutics is a Biotech company based in Boston, United States. It has raised $60.0M in total across 1 round, most recently a $60.0M Series A round in Jun 2021. Investors include Polaris Partners, Newpath Management and Cathay Capital.
Funding History
Jun 2021
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/kojin-therapeutics"><img src="https://indexed.vc/api/badge/company/kojin-therapeutics" alt="Kojin Therapeutics on Indexed.vc" width="260" height="76" /></a>